How Has the Clinical Trial Imaging Market Evolved Historically and What is its Current Size?
The clinical trial imaging market has seen considerable growth due to a variety of factors.
• The clinical trial imaging market has grown significantly in recent years. It will grow from $1.44 billion in 2024 to $1.58 billion in 2025, at a compound annual growth rate (CAGR) of 9.6%.
This growth is driven by the rising sales and distribution of clinical imaging software and services, increased healthcare spending, the growing risks of breast cancer, better infrastructure due to increased expenditure, and greater research and development investments by pharmaceutical and biotechnology companies.
What Is The Projected Growth Of The Clinical Trial Imaging Template Market?
The clinical trial imaging market is expected to maintain its strong growth trajectory in upcoming years.
• The clinical trial imaging market is projected to reach $2.26 billion by 2029 at a 9.3% CAGR. Growth factors include the rising prevalence of chronic diseases, R&D expenditures, and the aging population. Trends include innovations in molecular imaging, AI-driven analysis, and product innovation in imaging modalities.
What Are The Key Drivers Fueling Growth In The Clinical Trial Imaging Market?
The increasing prevalence of chronic diseases is expected to propel the clinical trial imaging market. Chronic diseases, due to environmental factors and aging populations, require advanced imaging solutions to monitor patient progress. Imaging technologies improve treatment adherence and patient satisfaction. The National Center for Biotechnology Information estimates a 99.5% rise in chronic illness prevalence by 2050.
What Are The Principal Market Segments In The Global Clinical Trial Imaging Industry?
The clinical trial imaging market covered in this report is segmented –
1) By Product And Services: Services, Software
2) By Modality: Computed Tomography, Magnetic Resonance Imaging, Echocardiography, Nuclear Medicine, Positron Emission Tomography, X-Ray, Ultrasound, Optical Coherence Tomography, Other Modalities
3) By Application: Oncology, Neurology, Cardiology, Endocrinology, Dermatology, Hematology, Other Applications
4) By Distributer: Direct Sales, Tender Sales
5) By End User: Contract Research Organizations, Pharmaceutical And Biotechnology Companies, Medical Device Manufacturers, Academic And Government Research Institutes, Other End-Users
Subsegments:
1) By Services: Imaging Services For Diagnostics, Image Acquisition Services, Image Analysis Services, Image Management And Archiving Services
2) By Software: Imaging Software For Analysis, Image Processing Software, Radiology Information Systems (RIS), Picture Archiving And Communication Systems (PACS)
Pre-Book The Clinical Trial Imaging Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Clinical Trial Imaging Market?
Companies in the clinical trial imaging market are developing cloud-based image tools to improve clinical trial efficiency. For example, in March 2023, Clarion launched a cloud-based image viewer tool that allows real-time viewing and manipulation of high-resolution medical images. This tool improves the image viewing process, making it easier, secure, and data privacy compliant.
Who Are the Key Players In The Clinical Trial Imaging Market?
Major companies operating in the clinical trial imaging market are:
• Koninklijke Philips N.V.
• Labcorp Drug Development
• Icon Plc
• PPD Inc.
• Syneos Health
• Charles River Laboratories
• Parexel International Corporation
• Clario
• Medpace Inc.
• Medidata Solution Inc.
• Biotelemetry Inc.
• WIRB-Copernicus Group
• ProScan Imaging LLC
• Invicro LLC
• Perspectum
• Radiant Sage LLC
• Worldcare Clinical LLC
• Intrinsic Imaging LLC
• Datatrak Inc.
• IXICO Plc
• Calyx Inc.
• Resonance Health Ltd.
• Anagram-ESIC SL
What Are The Regional Insights Into The Clinical Trial Imaging Market?
North America was the largest region in the clinical trial imaging market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
